Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Lupulon for the treatment of MRSA

July 10, 1997

Transcell and Merck & Co. collaborate on antibacterial research

July 9, 1997

Virend superior to placebo for topical treatment of genital herpes in AIDS patients

July 8, 1997

AmBisome NDA to be discussed at Antiviral Drugs Advisory Committee meeting

July 8, 1997

Antimalarial agents from Roche

July 7, 1997

Promising preliminary phase II results obtained for Protovir in bone marrow transplant patients

July 3, 1997

Antimicrobial/cytotoxic compound isolated from fungal strain by Boehringer Mannheim

July 3, 1997

Abelcet approved in Canada

July 2, 1997

Sequus signs marketing agreement for Amphocil

July 1, 1997

Update on new injectable streptogramin antibiotic

June 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...